ArticleRheumatology and therapy2025

Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study.

Alen Zabotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.